Literature DB >> 15592687

Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.

James M Farnham1, Nicola J Camp, Jeff Swensen, Sean V Tavtigian, Lisa A Cannon Albright.   

Abstract

Several genetic predisposition loci for prostate cancer have been identified through linkage analysis, and it is now generally recognized that no single gene is responsible for more than a small proportion of prostate cancers. However, published confirmations of these loci have been few, and failures to confirm have been frequent. The genetic etiology of prostate cancer is clearly complex and includes significant genetic heterogeneity, phenocopies, and reduced penetrance. Powerful analyses that involve robust statistics and methods to reduce genetic heterogeneity are therefore necessary. We have performed linkage analysis on 143 Utah pedigrees for the previously published Xq27-28 (HPCX) prostate cancer susceptibility locus. We employed a robust multipoint statistic (TLOD) and a novel splitting algorithm to reduce intra-familial heterogeneity by iteratively removing the top generation from the large Utah pedigrees. In a dataset containing pedigrees having no more than five generations, we observed a multipoint TLOD of 2.74 (P=0.0002), which is statistically significant after correction for multiple testing. For both the full-structure pedigrees (up to seven generations) and the smaller sub-pedigrees, the linkage evidence was much reduced. This study thus represents the first significant confirmation of HPCX (Xq27-28) and argues for the continued utility of large pedigrees in linkage analyses for complex diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15592687     DOI: 10.1007/s00439-004-1220-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Genetic linkage analysis of prostate cancer families to Xq27-28.

Authors:  M A Peters; G P Jarvik; M Janer; L Chakrabarti; S Kolb; E L Goode; M Gibbs; C C DuBois; E F Schuster; L Hood; E A Ostrander; J L Stanford
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

2.  Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.

Authors:  Sylvia Bochum; Thomas Paiss; Walther Vogel; Kathleen Herkommer; Richard Hautmann; Juergen Haeussler
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

3.  Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.

Authors:  E M Lange; H Chen; K Brierley; E E Perrone; C H Bock; E Gillanders; M E Ray; K A Cooney
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

4.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.

Authors:  P Berthon; A Valeri; A Cohen-Akenine; E Drelon; T Paiss; G Wöhr; A Latil; P Millasseau; I Mellah; N Cohen; H Blanché; C Bellané-Chantelot; F Demenais; P Teillac; A Le Duc; R de Petriconi; R Hautmann; I Chumakov; L Bachner; N J Maitland; R Lidereau; W Vogel; G Fournier; P Mangin; O Cussenot
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

5.  Allele frequency estimation from data on relatives.

Authors:  M Boehnke
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

6.  Linkage probability and its approximate confidence interval under possible heterogeneity.

Authors:  J Ott
Journal:  Genet Epidemiol Suppl       Date:  1986

7.  PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.

Authors:  G Cancel-Tassin; A Latil; A Valéri; P Mangin; G Fournier; P Berthon; O Cussenot
Journal:  Eur J Hum Genet       Date:  2001-02       Impact factor: 4.246

8.  Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.

Authors:  S L Neuhausen; J M Farnham; E Kort; S V Tavtigian; M H Skolnick; L A Cannon-Albright
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

9.  Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.

Authors:  J T Bergthorsson; G Johannesdottir; A Arason; K R Benediktsdottir; B A Agnarsson; J E Bailey-Wilson; E Gillanders; J Smith; J Trent; R B Barkardottir
Journal:  Hum Genet       Date:  2000-10       Impact factor: 4.132

10.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  7 in total

1.  A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.

Authors:  Brian L Yaspan; Kate M McReynolds; J Bradford Elmore; Joan P Breyer; Kevin M Bradley; Jeffrey R Smith
Journal:  Hum Genet       Date:  2008-03-19       Impact factor: 4.132

2.  Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.

Authors:  Natalay Kouprina; Nicholas C O Lee; Adam Pavlicek; Alexander Samoshkin; Jung-Hyun Kim; Hee-Sheung Lee; Sudhir Varma; William C Reinhold; John Otstot; Greg Solomon; Sean Davis; Paul S Meltzer; Johanna Schleutker; Vladimir Larionov
Journal:  Genes Chromosomes Cancer       Date:  2012-06-26       Impact factor: 5.006

3.  Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.

Authors:  Natalay Kouprina; Adam Pavlicek; Vladimir N Noskov; Greg Solomon; John Otstot; William Isaacs; John D Carpten; Jeffrey M Trent; Joanna Schleutker; J Carl Barrett; Jerzy Jurka; Vladimir Larionov
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

4.  A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Authors:  Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

5.  Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.

Authors:  Ilir Agalliu; Suzanne M Leanza; Lorie Smith; Jeffrey M Trent; John D Carpten; Joan E Bailey-Wilson; Robert D Burk
Journal:  Prostate       Date:  2010-11-01       Impact factor: 4.104

6.  Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.

Authors:  Tsuyoshi Hasegawa; Garrison J Glavich; Mary Pahuski; Aleena Short; O John Semmes; Lifang Yang; Vitold Galkin; Richard Drake; Aurora Esquela-Kerscher
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

7.  Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.

Authors:  Joan E Bailey-Wilson; Erica J Childs; Cheryl D Cropp; Daniel J Schaid; Jianfeng Xu; Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Asha George; Isaac Powell; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Mæhle; Pål Møller; Rosalind Eeles; Douglas Easton; Michelle Guy; Steve Edwards; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Janet L Stanford; Danielle M Karyadi; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Christiane Maier; Sylvia Bochum; Josef Hoegel; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; Geraldine Cancel-Tassin; Antoine Valeri; Olivier Cussenot; William B Isaacs
Journal:  BMC Med Genet       Date:  2012-06-19       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.